![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20210416005432/en/Akers-Biosciences-and-MyMD-Pharmaceuticals-Announce-Stockholder-Approval-of-Merger#:~:text=Akers%20Biosciences%20and%20MyMD%20Pharmaceuticals%20Announce%20Stockholder%20Approval%20of%20Merger,-Shares%20to%20commence&text=BALTIMORE%2D%2D(BUSINESS%20WIRE)%2D%2DAkers%20Biosciences%2C%20Inc.&text=Upon%20closing%2C%20the%20combined%20company%20will%20be%20named%20MyMD%20Pharmaceuticals,%E2%80%9D%20beginning%20April%2019%2C%202021.
https://www.pharmaceutical-technology.com/news/covid-19-temperature-transmission/
https://www.biospace.com/article/releases/akers-biosciences-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-and-amp-foti-llc-investigates-merger-of-akers-biosciences-inc-aker/?s=79
https://www.businesswire.com/news/home/20201202005600/en/Akers%E2%80%99-Proposed-Merger-Partner-MyMD-Pharmaceuticals-Announces-Issuance-of-Key-Patent#:~:text=Akers'%20Proposed%20Merger%20Partner%20MyMD%20Pharmaceuticals%20Announces%20Issuance%20of%20Key%20Patent,-Patent%20protects%20methods&text=BALTIMORE%2D%2D(BUSINESS%20WIRE)%2D%2D,%E2%80%9D)%20was%20issued%20US%20Pat.
https://www.biospace.com/article/releases/akers-biosciences-and-mymd-pharmaceuticals-sign-definitive-merger-agreement/?s=79